| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |